Aster Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.4K Buy
170
+50
+42% +$3.47K ﹤0.01% 743
2026
Q2
$7.55K Buy
+120
New +$7.67K ﹤0.01% 696
2025
Q1
– Sell
-218
Closed -$12.1K – 1648
2024
Q4
$12.1K Buy
+218
New +$9.9K ﹤0.01% 729

Other funds holding TARS

Aster Capital Management's TARS Position: Q3 2026 in Review

Aster Capital Management increased its Tarsus Pharmaceuticals (TARS) stake by 42% in Q3 2026, buying an estimated $3.47K and bringing the position to 170 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #743.

Aster Capital Management first reported a position in TARS in Q4 2024 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Aster Capital Management held 170 shares of Tarsus Pharmaceuticals worth $13.4K as of Q3 2026.
  • Aster Capital Management bought 50 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $3.47K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #743 holding.
  • Aster Capital Management first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.